Along with their role in OSCC, IFIT1 and IFIT3 have recently been shown to contribute to the progression of pancreatic cancer, which exhibits a 5-year overall survival rate of about 7% [48,57,58,59,60]. Here, IFIT3 is linked to pancreatic neoplasm.